251 related articles for article (PubMed ID: 26177322)
1. Diagnostic Approach to Neuroendocrine Neoplasms of the Gastrointestinal Tract and Pancreas.
Uccella S; Sessa F; La Rosa S
Turk Patoloji Derg; 2015; 31 Suppl 1():113-27. PubMed ID: 26177322
[TBL] [Abstract][Full Text] [Related]
2. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U
Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861
[TBL] [Abstract][Full Text] [Related]
3. Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining.
Jamali M; Chetty R
Endocr Pathol; 2008; 19(4):282-8. PubMed ID: 18931958
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.
Uccella S; La Rosa S; Volante M; Papotti M
Endocr Pathol; 2018 Jun; 29(2):150-168. PubMed ID: 29520563
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of new classification of gastroenteropancreatic neuroendocrine neoplasms].
Zhu XZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jan; 16(1):12-4. PubMed ID: 23691561
[TBL] [Abstract][Full Text] [Related]
6. High-grade poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: from morphology to proliferation and back.
La Rosa S; Sessa F
Endocr Pathol; 2014 Jun; 25(2):193-8. PubMed ID: 24715269
[TBL] [Abstract][Full Text] [Related]
7. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
Klöppel G
Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine neoplasms of the gastrointestinal tract: classification, pathologic basis, and imaging features.
Chang S; Choi D; Lee SJ; Lee WJ; Park MH; Kim SW; Lee DK; Jang KT
Radiographics; 2007; 27(6):1667-79. PubMed ID: 18025510
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): what's better?
Milione M
Endocrine; 2018 Jan; 59(1):1-3. PubMed ID: 28417314
[No Abstract] [Full Text] [Related]
10. Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms.
Kidd M; Modlin I; Öberg K
Nat Rev Clin Oncol; 2016 Nov; 13(11):691-705. PubMed ID: 27273044
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic imaging approach to gastro-entero-pancreatic carcinomas of neuroendocrine origin - single NET center experience in Poland.
Cwikla JB; Nasierowska-Guttmejer A; Jeziorski KG; Cichocki A; Zgliczynski W; Stepień K; Seklecka N; Durlik M; Malkowski B; Walecki J
Neuro Endocrinol Lett; 2007 Dec; 28(6):789-800. PubMed ID: 18063942
[TBL] [Abstract][Full Text] [Related]
12. Primary hepatic neuroendocrine tumor after 4 years tumor-free follow-up.
Lambrescu IM; Martin S; Cima L; Herlea V; Badiu C; Fica S
J Gastrointestin Liver Dis; 2015 Jun; 24(2):241-4. PubMed ID: 26114185
[TBL] [Abstract][Full Text] [Related]
13. Clinico-morphological analysis of the neuroendocrine neoplasms of the gastroenteropancreatic system.
Delektorskaya VV; Kozlov NA; Chemeris GY
Klin Lab Diagn; 2013 Oct; (10):48-50, 10-3. PubMed ID: 24640093
[TBL] [Abstract][Full Text] [Related]
14. Digital Image Analysis of Ki67 Heterogeneity Improves the Diagnosis and Prognosis of Gastroenteropancreatic Neuroendocrine Neoplasms.
Zhang M; Tan C; Wang X; Ding X; Zhang B; Yang Z; Wang Y; Sheng W; Huang D
Mod Pathol; 2023 Jan; 36(1):100017. PubMed ID: 36788066
[TBL] [Abstract][Full Text] [Related]
15. New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
Yin F; Wu ZH; Lai JP
World J Gastroenterol; 2022 May; 28(17):1751-1767. PubMed ID: 35633912
[TBL] [Abstract][Full Text] [Related]
16. An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology.
Chetty R
Arch Pathol Lab Med; 2008 Aug; 132(8):1285-9. PubMed ID: 18684027
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications.
Fazio N; Milione M
Cancer Treat Rev; 2016 Nov; 50():61-67. PubMed ID: 27636009
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification.
Anlauf M
Horm Metab Res; 2011 Nov; 43(12):825-31. PubMed ID: 22105474
[TBL] [Abstract][Full Text] [Related]
19. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS
Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283
[TBL] [Abstract][Full Text] [Related]
20. [Neuro-endocrine tumors of the gastrointestinal tract: epidemiology, classification, prognosis, diagnosis and therapeutic modalities].
Salih HR; Hartmann JT
Praxis (Bern 1994); 2005 Feb; 94(8):291-302. PubMed ID: 15779611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]